Establishing final infarct volume: Stroke lesion evolution past 30 days is insignificant

Martin R. Gaudinski, Erica C. Henning, Aaron Miracle, Marie Luby, Steven Warach, Lawrence L. Latour

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Background and Purpose: Lesion volume measured on MRI has been used as an objective surrogate marker for outcome in clinical trials. However, lesion volumes vary over time because of edema and tissue loss. This study aims to determine if lesion volumes measured at 30 and 90 days after ictus significantly differ. Methods: We performed a retrospective study of 18 patients who had acute (<24 hours) DWI and follow-up fluid-attenuated inversion recovery imaging at 5, 30, and 90 days. Two expert readers segmented lesions and the mean volumes of both reads were used in all statistical analyses. Results: Patient age was 65.8 (SD, 13.7) years and median NIHSS at baseline was 11.5. Inter-rater variability for lesion volume measurements was 3.7 (5.8) mL. Acute DWI volume was 19.3 (17.3) mL. Fluid-attenuated inversion recovery volumes for 5, 30, and 90 days were 34.3 (23.5), 18.6 (14.0), and 15.9 (13.8) mL, respectively. These volumes differed significantly (P<0.001). Linear regression revealed a strong correlation (r≤0.96; P<0.001) between lesion volumes at 30 and 90 days with a slope that did not vary significantly from 1.0 (P≤0.448). Conclusions: Lesions continue to evolve between 5 and 90 days, but by 30 days lesion volume approaches final infarct volume. While clinical response is the most meaningful outcome measure, our findings suggest that lesion volumes measured at 30 days may provide a sufficient approximation for final infarct volume for use in early phase clinical trials.

Original languageEnglish (US)
Pages (from-to)2765-2768
Number of pages4
JournalStroke
Volume39
Issue number10
DOIs
StatePublished - Oct 1 2008

Fingerprint

Stroke Volume
Clinical Trials
Linear Models
Edema
Retrospective Studies
Biomarkers
Outcome Assessment (Health Care)

Keywords

  • Final infarct volume
  • Fluid-attenuated inversion recovery
  • Lesion volume evolution
  • Magnetic resonance imaging
  • Stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Clinical Neurology
  • Advanced and Specialized Nursing
  • Medicine(all)

Cite this

Gaudinski, M. R., Henning, E. C., Miracle, A., Luby, M., Warach, S., & Latour, L. L. (2008). Establishing final infarct volume: Stroke lesion evolution past 30 days is insignificant. Stroke, 39(10), 2765-2768. https://doi.org/10.1161/STROKEAHA.107.512269

Establishing final infarct volume : Stroke lesion evolution past 30 days is insignificant. / Gaudinski, Martin R.; Henning, Erica C.; Miracle, Aaron; Luby, Marie; Warach, Steven; Latour, Lawrence L.

In: Stroke, Vol. 39, No. 10, 01.10.2008, p. 2765-2768.

Research output: Contribution to journalArticle

Gaudinski, MR, Henning, EC, Miracle, A, Luby, M, Warach, S & Latour, LL 2008, 'Establishing final infarct volume: Stroke lesion evolution past 30 days is insignificant', Stroke, vol. 39, no. 10, pp. 2765-2768. https://doi.org/10.1161/STROKEAHA.107.512269
Gaudinski MR, Henning EC, Miracle A, Luby M, Warach S, Latour LL. Establishing final infarct volume: Stroke lesion evolution past 30 days is insignificant. Stroke. 2008 Oct 1;39(10):2765-2768. https://doi.org/10.1161/STROKEAHA.107.512269
Gaudinski, Martin R. ; Henning, Erica C. ; Miracle, Aaron ; Luby, Marie ; Warach, Steven ; Latour, Lawrence L. / Establishing final infarct volume : Stroke lesion evolution past 30 days is insignificant. In: Stroke. 2008 ; Vol. 39, No. 10. pp. 2765-2768.
@article{3f16e465aac24b989358fcd0a324e70f,
title = "Establishing final infarct volume: Stroke lesion evolution past 30 days is insignificant",
abstract = "Background and Purpose: Lesion volume measured on MRI has been used as an objective surrogate marker for outcome in clinical trials. However, lesion volumes vary over time because of edema and tissue loss. This study aims to determine if lesion volumes measured at 30 and 90 days after ictus significantly differ. Methods: We performed a retrospective study of 18 patients who had acute (<24 hours) DWI and follow-up fluid-attenuated inversion recovery imaging at 5, 30, and 90 days. Two expert readers segmented lesions and the mean volumes of both reads were used in all statistical analyses. Results: Patient age was 65.8 (SD, 13.7) years and median NIHSS at baseline was 11.5. Inter-rater variability for lesion volume measurements was 3.7 (5.8) mL. Acute DWI volume was 19.3 (17.3) mL. Fluid-attenuated inversion recovery volumes for 5, 30, and 90 days were 34.3 (23.5), 18.6 (14.0), and 15.9 (13.8) mL, respectively. These volumes differed significantly (P<0.001). Linear regression revealed a strong correlation (r≤0.96; P<0.001) between lesion volumes at 30 and 90 days with a slope that did not vary significantly from 1.0 (P≤0.448). Conclusions: Lesions continue to evolve between 5 and 90 days, but by 30 days lesion volume approaches final infarct volume. While clinical response is the most meaningful outcome measure, our findings suggest that lesion volumes measured at 30 days may provide a sufficient approximation for final infarct volume for use in early phase clinical trials.",
keywords = "Final infarct volume, Fluid-attenuated inversion recovery, Lesion volume evolution, Magnetic resonance imaging, Stroke",
author = "Gaudinski, {Martin R.} and Henning, {Erica C.} and Aaron Miracle and Marie Luby and Steven Warach and Latour, {Lawrence L.}",
year = "2008",
month = "10",
day = "1",
doi = "10.1161/STROKEAHA.107.512269",
language = "English (US)",
volume = "39",
pages = "2765--2768",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Establishing final infarct volume

T2 - Stroke lesion evolution past 30 days is insignificant

AU - Gaudinski, Martin R.

AU - Henning, Erica C.

AU - Miracle, Aaron

AU - Luby, Marie

AU - Warach, Steven

AU - Latour, Lawrence L.

PY - 2008/10/1

Y1 - 2008/10/1

N2 - Background and Purpose: Lesion volume measured on MRI has been used as an objective surrogate marker for outcome in clinical trials. However, lesion volumes vary over time because of edema and tissue loss. This study aims to determine if lesion volumes measured at 30 and 90 days after ictus significantly differ. Methods: We performed a retrospective study of 18 patients who had acute (<24 hours) DWI and follow-up fluid-attenuated inversion recovery imaging at 5, 30, and 90 days. Two expert readers segmented lesions and the mean volumes of both reads were used in all statistical analyses. Results: Patient age was 65.8 (SD, 13.7) years and median NIHSS at baseline was 11.5. Inter-rater variability for lesion volume measurements was 3.7 (5.8) mL. Acute DWI volume was 19.3 (17.3) mL. Fluid-attenuated inversion recovery volumes for 5, 30, and 90 days were 34.3 (23.5), 18.6 (14.0), and 15.9 (13.8) mL, respectively. These volumes differed significantly (P<0.001). Linear regression revealed a strong correlation (r≤0.96; P<0.001) between lesion volumes at 30 and 90 days with a slope that did not vary significantly from 1.0 (P≤0.448). Conclusions: Lesions continue to evolve between 5 and 90 days, but by 30 days lesion volume approaches final infarct volume. While clinical response is the most meaningful outcome measure, our findings suggest that lesion volumes measured at 30 days may provide a sufficient approximation for final infarct volume for use in early phase clinical trials.

AB - Background and Purpose: Lesion volume measured on MRI has been used as an objective surrogate marker for outcome in clinical trials. However, lesion volumes vary over time because of edema and tissue loss. This study aims to determine if lesion volumes measured at 30 and 90 days after ictus significantly differ. Methods: We performed a retrospective study of 18 patients who had acute (<24 hours) DWI and follow-up fluid-attenuated inversion recovery imaging at 5, 30, and 90 days. Two expert readers segmented lesions and the mean volumes of both reads were used in all statistical analyses. Results: Patient age was 65.8 (SD, 13.7) years and median NIHSS at baseline was 11.5. Inter-rater variability for lesion volume measurements was 3.7 (5.8) mL. Acute DWI volume was 19.3 (17.3) mL. Fluid-attenuated inversion recovery volumes for 5, 30, and 90 days were 34.3 (23.5), 18.6 (14.0), and 15.9 (13.8) mL, respectively. These volumes differed significantly (P<0.001). Linear regression revealed a strong correlation (r≤0.96; P<0.001) between lesion volumes at 30 and 90 days with a slope that did not vary significantly from 1.0 (P≤0.448). Conclusions: Lesions continue to evolve between 5 and 90 days, but by 30 days lesion volume approaches final infarct volume. While clinical response is the most meaningful outcome measure, our findings suggest that lesion volumes measured at 30 days may provide a sufficient approximation for final infarct volume for use in early phase clinical trials.

KW - Final infarct volume

KW - Fluid-attenuated inversion recovery

KW - Lesion volume evolution

KW - Magnetic resonance imaging

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=54049107725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54049107725&partnerID=8YFLogxK

U2 - 10.1161/STROKEAHA.107.512269

DO - 10.1161/STROKEAHA.107.512269

M3 - Article

C2 - 18635854

AN - SCOPUS:54049107725

VL - 39

SP - 2765

EP - 2768

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 10

ER -